306 related articles for article (PubMed ID: 15291997)
1. Surgical staging of ovarian low malignant potential tumors.
Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
[TBL] [Abstract][Full Text] [Related]
2. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
[TBL] [Abstract][Full Text] [Related]
3. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
Lea JS; Sheets EE; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Feb; 84(2):285-8. PubMed ID: 11812088
[TBL] [Abstract][Full Text] [Related]
4. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.
Djordjevic B; Malpica A
Am J Surg Pathol; 2012 Jul; 36(7):955-63. PubMed ID: 22613998
[TBL] [Abstract][Full Text] [Related]
5. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
6. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
Wingo SN; Knowles LM; Carrick KS; Miller DS; Schorge JO
Am J Obstet Gynecol; 2006 May; 194(5):e20-2. PubMed ID: 16647891
[TBL] [Abstract][Full Text] [Related]
7. Lymph node involvement in ovarian serous tumors of low malignant potential: a clinicopathologic study of thirty-six cases.
Djordjevic B; Malpica A
Am J Surg Pathol; 2010 Jan; 34(1):1-9. PubMed ID: 19898226
[TBL] [Abstract][Full Text] [Related]
8. Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
Cho YH; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2006 Dec; 103(3):878-82. PubMed ID: 16859736
[TBL] [Abstract][Full Text] [Related]
9. Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?
Pirimoglu ZM; Afsin Y; Guzelmeric K; Yilmaz M; Unal O; Turan MC
Arch Gynecol Obstet; 2008 May; 277(5):411-4. PubMed ID: 17940784
[TBL] [Abstract][Full Text] [Related]
10. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer.
Santillan A; Karam AK; Li AJ; Giuntoli R; Gardner GJ; Cass I; Karlan BY; Bristow RE
Gynecol Oncol; 2007 Mar; 104(3):686-90. PubMed ID: 17141302
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
Suh-Burgmann E
Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
[TBL] [Abstract][Full Text] [Related]
12. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
Yavuzcan A; Baloglu A; Cetinkaya B
Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
[TBL] [Abstract][Full Text] [Related]
13. Recurrence and prognostic factors in borderline ovarian tumors.
Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
[TBL] [Abstract][Full Text] [Related]
14. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer.
Goudge C; Bernhard S; Cloven NG; Morris P
Gynecol Oncol; 2004 May; 93(2):536-9. PubMed ID: 15099975
[TBL] [Abstract][Full Text] [Related]
15. Secondary cytoreductive surgery in patients presenting with isolated nodal recurrence of epithelial ovarian cancer.
Fotiou S; Aliki T; Petros Z; Ioanna S; Konstantinos V; Vasiliki M; George C
Gynecol Oncol; 2009 Aug; 114(2):178-82. PubMed ID: 19450872
[TBL] [Abstract][Full Text] [Related]
16. Outcomes after combined therapy including surgical resection in patients with epithelial ovarian cancer recurrence(s) exclusively in lymph nodes.
Uzan C; Morice P; Rey A; Pautier P; Camatte S; Lhommé C; Haie-Meder C; Duvillard P; Castaigne D
Ann Surg Oncol; 2004 Jul; 11(7):658-64. PubMed ID: 15197013
[TBL] [Abstract][Full Text] [Related]
17. Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
Cliby WA; Aletti GD; Wilson TO; Podratz KC
Gynecol Oncol; 2006 Dec; 103(3):797-801. PubMed ID: 17052746
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic spread among women with primary peritoneal carcinoma.
Eltabbakh GH; Mount SL
J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.
Sainz de la Cuesta R; Goff BA; Fuller AF; Nikrui N; Eichhorn JH; Rice LW
Obstet Gynecol; 1994 Jul; 84(1):1-7. PubMed ID: 8008300
[TBL] [Abstract][Full Text] [Related]
20. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
Aletti GD; Dowdy S; Podratz KC; Cliby WA
Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
